[MYGN] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
02-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -148.94%
YoY- -242.68%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 191,900 156,400 167,300 145,200 186,300 202,300 190,200 0.14%
PBT -61,200 -44,200 39,800 -43,700 -22,300 800 86,600 -
Tax 100 -9,100 15,200 -28,500 -1,700 1,600 5,600 -48.85%
NP -61,300 -35,100 24,600 -15,200 -20,600 -700 81,100 -
Tax Rate - - -38.19% - - -200.00% -6.47% -
Total Cost 253,200 191,500 142,700 160,400 206,900 203,000 109,100 15.05%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -31.94 -22.44 14.70 -10.47 -11.06 -0.35 42.64 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.75 -0.43 0.31 -0.20 -0.28 -0.01 1.18 -
EPS Diluted -0.75 -0.43 0.30 -0.20 -0.28 -0.01 1.15 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.